Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus

Background. An active device that downregulates abdominal vagal signalling has resulted in significant weight loss in feasibility studies. Objective. To prospectively evaluate the effect of intermittent vagal blocking (VBLOC) on weight loss, glycemic control, and blood pressure (BP) in obese subject...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shikora, S., Toouli, J., Herrera, M. F., Kulseng, B., Zulewski, H., Brancatisano, R., Kow, L., Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., Knudson, M. B., Billington, C. J.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2013
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745954/
https://ncbi.nlm.nih.gov/pubmed/23984050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/245683
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires